Terms: = Bone cancer AND MSH6, GTBP, P52701, 2956, ENSG00000116062, HSAP, HNPCC5 AND Treatment
7 results:
1. Constitutional Mismatch Repair Deficiency Syndrome as a Cause of Numerous Malignancies in a Teenage Patient-A Case Report.
Samborska M; Galli D; Achkar R; Thambyrajah S; Derwich K
J Pediatr Hematol Oncol; 2023 Oct; 45(7):e917-e920. PubMed ID: 37526375
[TBL] [Abstract] [Full Text] [Related]
2. Lynch syndrome-associated chordoma with high tumor mutational burden and significant response to immune checkpoint inhibitors.
Shinojima N; Ozono K; Yamamoto H; Abe S; Sasaki R; Tomita Y; Kai A; Mori R; Yamamoto T; Uekawa K; Matsui H; Nosaka K; Matsuzaki H; Komohara Y; Mikami Y; Mukasa A
Brain Tumor Pathol; 2023 Jul; 40(3):185-190. PubMed ID: 37086325
[TBL] [Abstract] [Full Text] [Related]
3. Expression of Programmed Cell Death-L1 (PD-L1) Protein and Mismatch Repair Mutations in Orbital Tumours-a Pilot Study.
AlSemari MA; Strianese D; Abu Safieh L; Al Hussain H; Abedalthagafi M; Edward DP
Eur J Ophthalmol; 2022 Sep; 32(5):3097-3102. PubMed ID: 34931541
[TBL] [Abstract] [Full Text] [Related]
4. Inhibitory effect of msh6 gene silencing in combination with cisplatin on cell proliferation of human osteosarcoma cell line MG63.
Liu HC; Zeng J; Zhang B; Liu XQ; Dai M
J Cell Physiol; 2019 Jun; 234(6):9358-9369. PubMed ID: 30456894
[TBL] [Abstract] [Full Text] [Related]
5. LuCaP Prostate cancer Patient-Derived Xenografts Reflect the Molecular Heterogeneity of Advanced Disease an--d Serve as Models for Evaluating cancer Therapeutics.
Nguyen HM; Vessella RL; Morrissey C; Brown LG; Coleman IM; Higano CS; Mostaghel EA; Zhang X; True LD; Lam HM; Roudier M; Lange PH; Nelson PS; Corey E
Prostate; 2017 May; 77(6):654-671. PubMed ID: 28156002
[TBL] [Abstract] [Full Text] [Related]
6. [Late phase II clinical study of KW-2307 in advanced/recurrent breast cancer patients (II)].
Tominaga T; Nomura Y; Horikoshi N; Takashima S; Kimura M; Koyama H; Kikkawa N; Toge T; Mitsuyama S; Morimoto T; Enomoto K; Wada T; Kimishima I; Niitani H;
Gan To Kagaku Ryoho; 2005 Jul; 32(7):983-90. PubMed ID: 16044960
[TBL] [Abstract] [Full Text] [Related]
7. Phase I clinical investigation of amonafide.
Saez R; Craig JB; Kuhn JG; Weiss GR; Koeller J; Phillips J; Havlin K; Harman G; Hardy J; Melink TJ
J Clin Oncol; 1989 Sep; 7(9):1351-8. PubMed ID: 2549205
[TBL] [Abstract] [Full Text] [Related]
